Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany

被引:22
作者
Bramesfeld, Anke
Grobe, Thomas
Schwartz, Friedrich Wilhelm
机构
[1] Hannover Med Sch, Dept Epidemiol Social Med & Hlth Syst Res, D-30625 Hannover, Germany
[2] Inst Social Med Epidemiol & Hlth Syst Res, Hannover, Germany
关键词
treatment of depression; sociodemographic characteristics; health insurance data; epidemiology; health service research;
D O I
10.1007/s00127-007-0225-9
中图分类号
R749 [精神病学];
学科分类号
100205 [精神病与精神卫生学];
摘要
Background Studies on the treatment of depression using epidemiological survey methods suggest a high level of under-treatment. Little is known about the characteristics of those people receiving treatment and indeed what kind of treatment they are likely to receive. Method Analysis of the data of a statutory health insurance company in Germany. Results In middle-aged groups, about 50% of those diagnosed as being depressed in outpatient care are prescribed antidepressants and/or psychotherapy in the course of a year. There is more pharmacologic treatment provided in rural areas and more psychotherapy in cities, suggesting that treatment is dependent upon service availability rather than evidence-based treatment decisions. Treatment rates are considerably lower in the very young and the very old and show gender bias. Young females receive less pharmacologic treatment than young males, and elderly men are, in general, treated less than women, suggesting under-treatment at least for these groups. Conclusions The low treatment rates following the diagnosis of depression in the young and the old require attention, in particular with respect to gender aspect.
引用
收藏
页码:740 / 746
页数:7
相关论文
共 29 条
[1]
Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55
[2]
Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P47
[3]
Andrews Gavin, 2000, J Ment Health Policy Econ, V3, P175, DOI 10.1002/mhp.96
[4]
[Anonymous], GEK GESUNDHEITSREPOR
[5]
Who is diagnosed as suffering from depression in the German statutory health care system? An analysis of health insurance data [J].
Bramesfeld, Anke ;
Grobe, Thomas G. ;
Schwartz, Friedrich Wilhelm .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2007, 22 (06) :397-403
[6]
Measuring quality of pharmacotherapy for depression in a national health care system [J].
Busch, SH ;
Leslie, D ;
Rosenheck, R .
MEDICAL CARE, 2004, 42 (06) :532-542
[7]
Busse R., 2004, Health Care Systems in Transition (HIT) - Germany. Copenhagen
[8]
Antidepressant use in children and adolescents in Germany [J].
Fegert, JM ;
Kölch, M ;
Zito, JM ;
Glaeske, G ;
Janhsen, K .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (1-2) :197-206
[9]
Treatment adequacy for anxiety and depressive disorders in six European countries [J].
Fernandez, A. ;
Haro, J. M. ;
Martinez-Alonso, M. ;
Demyttenaere, K. ;
Brugha, T. S. ;
Autonell, J. ;
De Girolamo, G. ;
Bernert, S. ;
Lepine, J. P. ;
Alonso, J. .
BRITISH JOURNAL OF PSYCHIATRY, 2007, 190 :172-173
[10]
FIEDLER G, 2005, SUIZIDE SUIZIDVERSUC